BridgeBio Pharma Inc vs Pinterest Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Pinterest Inc trades at $23.65 (market cap $13.45B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | PINS | |
|---|---|---|
Market Cap | $16.36B | $13.45B |
Sector | Health | Media |
52-Week High | $90.17 | $37.95 |
52-Week Low | $47.29 | $15.42 |
Enterprise Value | $18.14B | $13.37B |
Trailing returns across standard periods
Latest headlines on both assets
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →